Nazim Arain Shares The New Standard: Anticoagulation in Cirrhosis
Nazim Arain, Consultant Internal Medicine and Gastroenterologist at Almana Group of Hospitals, shared on LinkedIn:
”Anticoagulation in Cirrhosis: The New Standard
Patients with cirrhosis face an increased risk of thrombotic events like AF and VTE.
It’s now accepted that their coagulation is “rebalanced,” making anticoagulation the standard of care to reduce stroke/thrombosis risk!
The primary bleeding risk is linked to portal hypertension, NOT general clotting deficiency.
Direct Oral Anticoagulants (DOACs) can be considered for Child-Pugh A and Bpatients.
LMWH often preferred in Child-Pug-C.
Read the full review.”
Read the full review article here.
Article: Anticoagulation in cirrhosis
Authors: Lara Roberts
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation